Inventor · disambiguated record
Zheng Wang
Also filed as: WANG ZHENG · WANG ZHENG-PIN
55 granted patents·47 pending applications·417 citations·filing 1994–2025
98Inventor score
Files withSHANGHAI BAO PHARMACEUTICALS CO LTD10CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD6NAL PHARMACEUTICALS LTD5SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD5ASPIRA WOMENS HEALTH INC3
Top patents by PatentIndex Score
102 records- 0195US6960449B2Class characterization of circulating cancer cells isolated from body fluids and methods of useCELL WORKS DIAGNOSTICS INC·Filed 2000·Granted Nov 1, 2005·180 cites·19 claims
- 0294US12458647B2Macrocyclic derivative and use thereofGUANGZHOU JOYO PHARMATECH CO LTD·Filed 2025·Granted Nov 4, 2025·1 cites·30 claims
- 0392US10253030B2Crystal form, preparation method and intermediate of dihydropyrido ring compoundQILU PHARMACEUTICAL CO LTD·Filed 2016·Granted Apr 9, 2019·25 cites·26 claims
- 0490US8715715B2Dosage form for insertion into the mouthRYOO JE PHIL·Filed 2009·Granted May 6, 2014·15 cites·42 claims
- 0589US8771736B2Dosage form for insertion into the mouthNAL PHARMACEUTICALS LTD·Filed 2012·Granted Jul 8, 2014·10 cites·38 claims
- 0688US10294440B2Catalytic system for preparation of high branched alkane from olefinsSHANGHAI CHEMRUN CO LTD·Filed 2016·Granted May 21, 2019·5 cites·10 claims
- 0788US5962237AMethod of enriching rare cellsUNIV JOHNS HOPKINS MED·Filed 1997·Granted Oct 5, 1999·97 cites·37 claims
- 0885US7668664B2Design and selection of genetic targets for sequence resolved organism detection and identificationUS NAVY·Filed 2007·Granted Feb 23, 2010·5 cites·12 claims
- 0984US9156874B2Double-liver-targeting phosphoramidate and phosphonoamidate prodrugsNANJING MOLECULAR RES INC·Filed 2013·Granted Oct 13, 2015·21 cites·20 claims
- 1084US9095599B2O-(substituted benzyl) phosphoramidate compounds and therapeutic useCHANG JUNBIAO·Filed 2011·Granted Aug 4, 2015·16 cites·19 claims
- 1183US9114075B2Dosage form for insertion into the mouthNAL PHARMACEUTICALS LTD·Filed 2014·Granted Aug 25, 2015·4 cites·22 claims
- 1282US6316497B1Self-emulsifying systems containing anticancer medicamentABBOTT LAB·Filed 2001·Granted Nov 13, 2001·21 cites·10 claims
- 1381US11390877B2Blue-grained genes in wheat and application thereofUNIV CAPITAL NORMAL·Filed 2017·Granted Jul 19, 2022·4 cites·6 claims
- 1481US9114073B2Dosage form for insertion into the mouthNAL PHARMACEUTICALS LTD·Filed 2014·Granted Aug 25, 2015·3 cites·20 claims
- 1578US12319942B2Use of mutant of immunoglobulin degrading enzyme IdeESHANGHAI BAO PHARMACEUTICALS CO LTD·Filed 2024·Granted Jun 3, 2025·0 cites·14 claims
- 1678US9114074B2Dosage form for insertion into the mouthNAL PHARMACEUTICALS LTD·Filed 2014·Granted Aug 25, 2015·2 cites·21 claims
- 1777US10323046B2Method for preparing L-BPANEUBORON MEDTECH LTD·Filed 2018·Granted Jun 18, 2019·1 cites·17 claims
- 1874US9315755B2Catalytic system for preparation of high branched alkane from olefinsTANG YONG·Filed 2012·Granted Apr 19, 2016·2 cites·26 claims
- 1973US12116367B2Ring-modified proline short peptide compound and use thereofFUJIAN AKEYLINK BIOTECHNOLOGY CO LTD·Filed 2023·Granted Oct 15, 2024·0 cites·8 claims
- 2072US2022317126A1Biomarkers for ovarian cancer ctap3-related proteinsASPIRA WOMENS HEALTH INC·Filed 2021·Application pending·0 cites
- 2172US2024391920A1Ring-modified proline short peptide compound and use thereofFUJIAN AKEYLINK BIOTECHNOLOGY CO LTD·Filed 2024·Application pending·0 cites
- 2271US10399981B2Crystal form A of 7-(cyclopropylmethyl)-1-(((cis )-4-hydroxy-4-methylcyclohexyl)methyl)-3-methyl-1H-purine-2,6-(3H,7H)-dione for treating liver diseasesGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2016·Granted Sep 3, 2019·1 cites·17 claims
- 2371US2024254571A1Degenerate CRISPR Cas13a crRNAs for Detection of Highly Variable RNA SequencesUS GOV SEC NAVY·Filed 2024·Application pending·0 cites
- 2469US10428073B2Salt type and crystal type of 4H-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereofHUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC·Filed 2016·Granted Oct 1, 2019·1 cites·13 claims
- 2567US10912775B2Crystal form of orexin receptor antagonist compound, and preparation method and application thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2020·Granted Feb 9, 2021·0 cites·7 claims
- 2667US10633347B2Crystal form B of 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-oneSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2019·Granted Apr 28, 2020·0 cites·10 claims
- 2767US10227339B2Salt form and crystal form of 1,2,5-thiadiazolidin-1,1-dioxide, preparation method thereof and intermediateJIANGSU KANION PARMACEUTICAL CO LTD·Filed 2016·Granted Mar 12, 2019·1 cites·8 claims
- 2866US10941150B2Salt type and crystal type of 4h-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereofHUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC·Filed 2019·Granted Mar 9, 2021·0 cites·12 claims
- 2966US2010075342A1Biomarker for ovarian cancer CTAP3-related proteinsUNIV JOHNS HOPKINS·Filed 2009·Application pending·0 cites
- 3065US10874674B2Crystal form of orexin receptor antagonist compound, and preparation method and application thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2020·Granted Dec 29, 2020·0 cites·5 claims
- 3165US10858322B2Process for preparing 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[D]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-oneSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2020·Granted Dec 8, 2020·0 cites·8 claims
- 3265US9119776B2Dosage form for insertion into the mouthNAL PHARMACEUTICALS LTD·Filed 2014·Granted Sep 1, 2015·0 cites·20 claims
- 3364US10898486B2Crystal form of orexin receptor antagonist compound, and preparation method and application thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2020·Granted Jan 26, 2021·0 cites·6 claims
- 3464US9816995B2Biomarker for ovarian cancer CTAP3-related proteinsUNIV JOHNS HOPKINS·Filed 2014·Granted Nov 14, 2017·0 cites·1 claims
- 3564US2025268907A1Macrocyclic derivative and use thereofGUANGZHOU JOYO PHARMATECH CO LTD·Filed 2025·Application pending·0 cites
- 3662US11255857B2Biomarkers for ovarian cancer CTAP3-related proteinsASPIRA WOMENS HEALTH INC·Filed 2017·Granted Feb 22, 2022·0 cites·6 claims
- 3762US8900634B2Diethylstilbestrol dosage form and methods of treatment using thereofRYOO JE PHIL·Filed 2011·Granted Dec 2, 2014·1 cites·17 claims
- 3862US2024158373A1Ring-modified proline short peptide compound and use thereofFUJIAN AKEYLINK BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 3961US10442811B2Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-D] pyrimidin-4-amine, preparation process and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Oct 15, 2019·0 cites·20 claims
- 4061US10227309B2Crystal form A of 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo [d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-oneSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2016·Granted Mar 12, 2019·0 cites·9 claims
- 4160US2021181207A1Biomarkers for Ovarian Cancer: B2 MicroglobulinASPIRA WOMENS HEALTH INC·Filed 2020·Application pending·0 cites
- 4260US2025257346A1Use of mutant of immunoglobulin degrading enzyme ideeSHANGHAI BAO PHARMACEUTICALS CO LTD·Filed 2025·Application pending·0 cites
- 4359US10947245B2Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine for inhibiting toll-like receptor activityCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Mar 16, 2021·0 cites·20 claims
- 4459US2024417403A1Crystalline forms of quinazoline derivatives, preparation, composition and use thereofHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 4559US2025244762A1Architecture and method for ar tag detection and localization for mobile robotsBEAR ROBOTICS INC·Filed 2025·Application pending·0 cites
- 4659US2025163029A1Pyridone or pyrimidone derivative and application thereofMEDSHINE DISCOVERY INC·Filed 2023·Application pending·0 cites
- 4758US10947202B2Sodium ion channel inhibitors and pharmaceutically acceptable salts and polymorphs thereof and uses thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2019·Granted Mar 16, 2021·0 cites·9 claims
- 4856US2020368241A1Tlr7 agonist maleate salt, crystalline forms c, d and e thereof, preparation methods and uses of maleate salt and crystalline formsCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
- 4956US2025145730A1Anti-immunoglobulin degrading enzyme-digested fc variantSHANGHAI BAO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 5056US2025043026A1Fc polypeptide having altered glycosylation modificationSHANGHAI BAO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
Showing the top 50 of 102 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Zheng Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →